REG 2023

Free Webinar:
Integrated Pharma Regulatory Strategy
as the Key to Market Advantage.

During this webinar, our experts will describe how integrating all functions into a comprehensive and holistic regulatory strategy is the key for optimizing regulatory frameworks, removing risk along the strategic regulatory pathway and ultimately reducing time to market for key innovative therapies.

In collaboration with TOPRA – The Organization for Professionals in Regulatory Affairs

Jayne Hunt and Kate Coleman from Arriello

Jayne Hunt Official

Jayne has over 30 years strategic & operational Regulatory Affairs expertise in pre & post marketing across the EU, UK, US, and other territories.

She has experience in multiple areas including ATMPs, biologics, small molecules, marketing authorizations and pre-marketing development activities.

This includes supporting interactions and meetings with regulatory agencies in Europe (National and EMA) as well as with the FDA & Health Canada.

Jayne holds a PhD in Biochemistry from the University of London.

Kate Coleman Official

Kate has over 20 years’ experience in Quality Assurance, Sterility Assurance, Microbiology and Quality Control, and has worked across ATMPs, Biologics, Sterile Fill Finish, Vaccines, APIs and Oral Dose platforms.

Over her career to date, Kate has served as a practicing QP, Principal Consultant, and qualified Lead Auditor. She is also a subject matter expert in Commercialization readiness, Supply Chain GDP, MAH Compliance, Quality Risk Management, New Facility Design/Start Up, Quality Control and Sterility Assurance. In her previous role before joining Arriello, she was Senior Director for Quality Management and Compliance, and Head of QMC for Ireland and UK.

Kate is particularly passionate about the management of risk and the interdependence of Regulatory and Quality, as companies develop their strategies and processes and look more holistically at what they need, rather than operating in silos.

Watch the webinar here:

free webinar topra

Download the presentation: